The National Institute for Health and Clinical Excellence (NICE) is recommending that doctors use a new blood pressure device in early detection of atrial fibrillation (AF). The condition is known to significantly increase a patient’s chances of having a stroke and can be fatal, but many patients do not know that they have AF. This new device may go a long way in helping doctors detect AF early.
NICE has stated that doctors should monitor a patient’s blood pressure if they think that it’s high, and that they should use the WatchBP Home device in detecting AF. NICE believes that medics in the UK could increase their discovery of AF if they were use the device.
“The evidence indicates that the device can offer advantages in detecting atrial fibrillation opportunistically while measuring blood pressure, and that using the device in primary care could increase the detection rate of atrial fibrillation compared with taking the pulse by hand,” says professor Carole Longson, director of the NICE Centre for Health Technology Evaluation.
Atrial fibrillation is a condition that is caused by patients suffering from irregular heartbeats and flutters. The condition can prove fatal for some patients, which is why early detection is key to helping patients manage the condition. Once AF is detected, many of them are given prescription drugs that help to prevent strokes and recurrences in AF. One of those medications is Multaq. Multaq has been linked to serious condition, which include liver failure and a worsening of the heart condition. Most recently, the drug has been linked to lung disease and pulmonary toxicity as well.
If you or a family member has been diagnosed with liver failure, lung disease, pulmonary toxicity or a worsening of your heart condition after taking Multaq, contact attorney Greg Jones for a free consultation today. I am experienced at fighting Multaq lawsuits and may be able to get you money for your injuries.